Investors Backing Strong funding history with a total funding of 94M and notable Series A1 investment of 16.4M including Johnson & Johnson Innovation signals credibility and potential for rapid clinical development collaboration opportunities.

Clinical Stage Focus As a clinical-stage medical device company developing less invasive solutions, there are clear opportunities to partner on trials, KOL engagement, and early-access programs with hospitals and ASC networks seeking innovative GI and endoscopic solutions.

Market Positioning Recognized as Emerging MedTech Company of the Year and operating in a competitive landscape with large players suggests targeting mid-market hospitals, private clinics, and regional distributors where differentiated, minimally invasive devices can win adoption.

Technology & Platform Existing tech stack supports online presence and eCommerce readiness; leverage digital channels for clinician education, product demonstrations, and direct-to-clinic outreach to accelerate product qualification and purchasing cycles.

Growth Opportunity Revenue in the low to mid single-digit millions with substantial funding runway presents a window to pursue strategic partnerships, larger distributor agreements, and joint ventures with established endoscopy and GI device manufacturers.